Showing results (751-760 of 950) with videos related to
Sort By:
Pageof 95
JCI Insight|April 17, 2019
Parkin does not prevent accelerated cardiac aging in mitochondrial DNA mutator miceBenjamin P Woodall, Amabel M Orogo, Rita H Najor, et al.The Journal of Bone and Joint Surgery. American Volume|December 5, 2019
The Usefulness of Meta-Analyses to Hip and Knee SurgeonsKwan J Park, Bradley S Lambert, Landon D Brown, et al.Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 29, 2017
Association of altered collagen content and lysyl oxidase expression in degenerative mitral valve diseaseK-Raman Purushothaman, Meerarani Purushothaman, Irene C Turnbull, et al.Sports (Basel, Switzerland)|June 19, 2018
Profiling of Junior College Football Players and Differences between Position GroupsRobert G Lockie, Adrina Lazar, Ashley J Orjalo, et al.Forensic Science International|September 26, 2016
Old hearts for modern investigations: CT and MR for archaeological human hearts remainsF Z Mokrane, R Colleter, S Duchesne, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|August 20, 2009
Current pharmacological approach to restore endothelial dysfunctionD Dobarro, M C Gómez-Rubín, A Sanchez-Recalde, et al.Journal of the American College of Cardiology|October 14, 2008
Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaquePedro R Moreno, K Raman Purushothaman, Meera Purushothaman, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|September 18, 2012
Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosisMeerarani Purushothaman, Prakash Krishnan, K-Raman Purushothaman, et al.Carbohydrate Research|November 25, 2010
Characterization of physical interaction between Casiopeina III-ia and chitosan. Toward a Cas III-ia drug delivery systemJ E Miranda-Calderón, L Medina-Torres, M Tinoco-Mendez, et al.Revista Espanola De Cardiologia|November 1, 1996
[Reversible severe ventricular dysfunction in female patient with eclampsia and HELLP syndrome]R Moreno Gómez, J Elízaga Corrales, E López de Sá, et al.Pageof 95